American Society of Hematology

Figure 2

$Figure 2. PFS and OS. (A) PFS in the intent-to-treat population. (B) OS in the intent-to-treat population. (C) PFS in patients with disease refractory to LEN. (D) OS in patients with disease refractory to LEN. (E) PFS in patients with disease refractory to both LEN and BORT. (F) OS in patients with disease refractory to both LEN and BORT.$

PFS and OS. (A) PFS in the intent-to-treat population. (B) OS in the intent-to-treat population. (C) PFS in patients with disease refractory to LEN. (D) OS in patients with disease refractory to LEN. (E) PFS in patients with disease refractory to both LEN and BORT. (F) OS in patients with disease refractory to both LEN and BORT.

This Feature Is Available To Subscribers Only